Annual CFF
N/A
December 31, 2024
Summary
- IRMD annual cash flow from financing activities is not available.
Performance
IRMD Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly CFF
N/A
December 31, 2024
Summary
- IRMD quarterly cash flow from financing activities is not available.
Performance
IRMD Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM CFF
N/A
December 31, 2024
Summary
- IRMD TTM cash flow from financing activities is not available.
Performance
IRMD TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
IRMD Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
IRMD Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time |
IRadimed Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$1.92 M(-2.1%) | -$12.18 M(+18.3%) |
| Jun 2024 | - | -$1.96 M(-75.6%) | -$10.29 M(+22.2%) |
| Mar 2024 | - | -$8.04 M(+2961.7%) | -$8.42 M(-38.3%) |
| Dec 2023 | -$13.66 M(+7.5%) | -$262.60 K(+736.3%) | -$13.66 M(+0.5%) |
| Sep 2023 | - | -$31.40 K(-65.0%) | -$13.59 M(+0.6%) |
| Jun 2023 | - | -$89.80 K(-99.3%) | -$13.51 M(+0.6%) |
| Mar 2023 | - | -$13.27 M(+6586.5%) | -$13.42 M(+5.7%) |
| Dec 2022 | -$12.71 M(<-9900.0%) | -$198.50 K(-479.5%) | -$12.71 M(+1.6%) |
| Sep 2022 | - | $52.30 K(-1017.5%) | -$12.51 M(+0.0%) |
| Jun 2022 | - | -$5700.00(-100.0%) | -$12.50 M(+0.1%) |
| Mar 2022 | - | -$12.55 M(<-9900.0%) | -$12.49 M(<-9900.0%) |
| Dec 2021 | $24.40 K(-95.3%) | $2200.00(-95.9%) | $24.60 K(-109.6%) |
| Sep 2021 | - | $54.20 K(+1131.8%) | -$255.10 K(-145.6%) |
| Jun 2021 | - | $4400.00(-112.2%) | $558.90 K(+87.6%) |
| Mar 2021 | - | -$36.20 K(-87.0%) | $297.90 K(-43.0%) |
| Dec 2020 | $522.50 K(-74.1%) | -$277.50 K(-132.0%) | $522.40 K(-31.3%) |
| Sep 2020 | - | $868.20 K(-438.3%) | $759.90 K(-52.5%) |
| Jun 2020 | - | -$256.60 K(-236.3%) | $1.60 M(-9.8%) |
| Mar 2020 | - | $188.30 K(-570.8%) | $1.77 M(-12.2%) |
| Dec 2019 | $2.02 M(+117.2%) | -$40.00 K(-102.3%) | $2.02 M(+14.0%) |
| Sep 2019 | - | $1.71 M(-2178.0%) | $1.77 M(+66.8%) |
| Jun 2019 | - | -$82.20 K(-118.9%) | $1.06 M(-16.5%) |
| Mar 2019 | - | $434.20 K(-250.6%) | $1.27 M(+36.9%) |
| Dec 2018 | $929.90 K | -$288.30 K(-128.9%) | $929.80 K(-17.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2018 | - | $998.70 K(+680.8%) | $1.13 M(-954.3%) |
| Jun 2018 | - | $127.90 K(+39.8%) | -$132.50 K(-92.6%) |
| Mar 2018 | - | $91.50 K(-206.1%) | -$1.80 M(-5.4%) |
| Dec 2017 | -$1.90 M(-79.2%) | -$86.20 K(-67.6%) | -$1.90 M(+9.8%) |
| Sep 2017 | - | -$265.70 K(-82.7%) | -$1.73 M(+64.2%) |
| Jun 2017 | - | -$1.54 M(>+9900.0%) | -$1.05 M(-71.9%) |
| Mar 2017 | - | -$10.90 K(-113.1%) | -$3.75 M(-58.8%) |
| Dec 2016 | -$9.12 M(-492.0%) | $83.20 K(-79.8%) | -$9.12 M(+12.9%) |
| Sep 2016 | - | $411.10 K(-109.7%) | -$8.07 M(+5.6%) |
| Jun 2016 | - | -$4.24 M(-21.2%) | -$7.65 M(+128.1%) |
| Mar 2016 | - | -$5.38 M(-576.9%) | -$3.35 M(-244.2%) |
| Dec 2015 | $2.33 M(-81.7%) | $1.13 M(+34.6%) | $2.33 M(+58.3%) |
| Sep 2015 | - | $837.70 K(+1369.6%) | $1.47 M(-88.9%) |
| Jun 2015 | - | $57.00 K(-81.3%) | $13.28 M(+2.0%) |
| Mar 2015 | - | $304.30 K(+12.6%) | $13.02 M(+2.4%) |
| Dec 2014 | $12.71 M(-2575.6%) | $270.20 K(-97.9%) | $12.71 M(+4.7%) |
| Sep 2014 | - | $12.65 M(-6324.9%) | $12.14 M(-1785.9%) |
| Jun 2014 | - | -$203.20 K(+3125.4%) | -$720.10 K(+38.6%) |
| Mar 2014 | - | -$6300.00(-97.9%) | -$519.60 K(+1.2%) |
| Dec 2013 | -$513.40 K(+115.3%) | -$299.10 K(+41.4%) | -$513.30 K(+139.6%) |
| Sep 2013 | - | -$211.50 K(+7733.3%) | -$214.20 K(+7833.3%) |
| Jun 2013 | - | -$2700.00(<-9900.0%) | -$2700.00(<-9900.0%) |
| Mar 2013 | - | $0.00 | $0.00 |
| Dec 2012 | -$238.50 K | - | - |
FAQ
- What is the all time high annual CFF for IRadimed?
- What is the all time high quarterly CFF for IRadimed?
- What is the all time high TTM CFF for IRadimed?
What is the all time high annual CFF for IRadimed?
IRadimed all-time high annual cash flow from financing activities is $12.71 M
What is the all time high quarterly CFF for IRadimed?
IRadimed all-time high quarterly cash flow from financing activities is $12.65 M
What is the all time high TTM CFF for IRadimed?
IRadimed all-time high TTM cash flow from financing activities is $13.28 M